After Hours: Dead or Alive (Podcast)
With a million dollars per body in play, some in Congress are asking whether some authorities are too quick to declare an organ donor to be “dead.” Listen below:
With a million dollars per body in play, some in Congress are asking whether some authorities are too quick to declare an organ donor to be “dead.” Listen below:
The following is from Sen. Marsha Blackburn’s office. US Senator Marsha Blackburn (R-Tenn.) sent a letter to Robert Malone, Director of Exempt Organizations and Government Entities at the Internal Revenue Service, regarding Planned Parenthood offering neurotoxin injections similar to Botox and
Sixteen years after the Affordable Care Act or Obamacare became law prescription drug prices remain one of the most baffling and infuriating parts of healthcare for everyday Americans. Expanding insurance promised affordability, but instead it supercharged costs. Today, we pull
Why drug prices skyrocketed after the Affordable Care Act and what you can do about it. Listen below:
After Hours: America’s Drug Price Disaster (Podcast) Read More »
Add-ons are heavily promoted by drugmakers, and experts are calling for more scrutiny to ensure patient care remains the priority over industry profits.
Add-On’ Drugs Raise Questions About Safety and Cost (Podcast) Read More »
Some hugely profitable drugs are targeted under new price controls. Big Pharma has been spending millions to fight them tooth and nail. Listen below:
The following is from Gallup News. A new Gallup and West Health survey finds that 46% of Americans say the country is headed in the wrong direction regarding healthcare policy under President-elect Donald Trump. About 31% say it’s on the
(GALLUP) Nearly half say US healthcare is headed in the wrong direction Read More »
Pharmacy Benefit Managers (PBMs) are powerful, unseen middlemen impacting drug prices in a big way. The debate is over whether they’re saving you money or costing you money— and possibly costing lives. Listen below: